Cargando…

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

Neuropsychiatric symptoms (NPS) have been recently addressed as risk factors of conversion to Alzheimer’s disease (AD) and other dementia types in patients diagnosed with Mild Cognitive Impairment (MCI). Our aim was to determine profiles based on the prominent NPS in MCI patients and to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberto, Natalia, Portella, Maria J., Marquié, Marta, Alegret, Montserrat, Hernández, Isabel, Mauleón, Ana, Rosende-Roca, Maitee, Abdelnour, Carla, de Antonio, Ester Esteban, Gil, Silvia, Tartari, Juan P., Vargas, Liliana, Espinosa, Ana, Ortega, Gemma, Pérez-Cordón, Alba, Sanabria, Ángela, Orellana, Adelina, de Rojas, Itziar, Moreno-Grau, Sonia, Montrreal, Laura, Alarcón-Martín, Emilio, Ruíz, Agustín, Tárraga, Lluís, Boada, Mercè, Valero, Sergi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979780/ https://www.ncbi.nlm.nih.gov/pubmed/33742011 http://dx.doi.org/10.1038/s41598-021-83126-y

Ejemplares similares

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
por: Roberto, Natalia, et al.
Publicado: (2021)

Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Sergi, Valero, et al.
Publicado: (2020)

Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Valero, Sergi, et al.
Publicado: (2021)

From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery
por: Alegret, Montserrat, et al.
Publicado: (2021)

Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
por: Alegret, Montserrat, et al.
Publicado: (2022)

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2013)

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2014)

A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease
por: Alegret, Montserrat, et al.
Publicado: (2020)

Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
por: Orellana, Adelina, et al.
Publicado: (2022)

Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain
por: Benaque, Alba, et al.
Publicado: (2020)

Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer’s Disease Dementia: A Latent Class Analysis
por: Rosende-Roca, Maitée, et al.
Publicado: (2022)

Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
por: Pérez-Cordón, Alba, et al.
Publicado: (2020)

Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic
por: Sánchez, Domingo, et al.
Publicado: (2020)

Visual impairment in aging and cognitive decline: experience in a Memory Clinic
por: Marquié, Marta, et al.
Publicado: (2019)

The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline
por: Sanabria, Angela, et al.
Publicado: (2018)

Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
por: Marquié, Marta, et al.
Publicado: (2020)

The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
por: Marquié, Marta, et al.
Publicado: (2023)

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic
por: Cañabate, Pilar, et al.
Publicado: (2017)

Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2022)

Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
por: Ortega, G., et al.
Publicado: (2021)

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2023)

Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2018)

Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2019)

The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening
por: Rosende-Roca, Maitee, et al.
Publicado: (2021)

BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
por: Esteban de Antonio, Ester, et al.
Publicado: (2021)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
por: Morató, Xavier, et al.
Publicado: (2023)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

Genome-wide significant risk factors on chromosome 19 and the APOE locus
por: Moreno-Grau, Sonia, et al.
Publicado: (2018)

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults
por: de Rojas, Itziar, et al.
Publicado: (2023)

Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
por: García-Gutiérrez, Fernando, et al.
Publicado: (2023)

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
por: Cano, Amanda, et al.
Publicado: (2023)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
por: Muñoz, Nathalia, et al.
Publicado: (2020)

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
por: Alonso-Lana, Silvia, et al.
Publicado: (2020)

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
por: de Rojas, Itziar, et al.
Publicado: (2018)

Managing Clinical Trials for Alzheimer’s Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain
por: Abdelnour, Carla, et al.
Publicado: (2020)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
por: Pascual-Lucas, María, et al.
Publicado: (2023)

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research
por: Boada, Mercè, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sufhfpj6r5fnf5mmhvfga0shhv